Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Lancet HIV. 2018 Sep 23;5(10):e553–e559. doi: 10.1016/S2352-3018(18)30214-5

Figure 2. d-dimer, hs-CRP and IL-6 levels during the trial.

Figure 2.

Box and whiskers plots show median (line), interquartile range (box) and whiskers (defined as UQ+1·5xIQR and LQ-1·5xIQR) for the two groups (vorapaxar grey, placebo black boxes) during the trial. Potential outliers are not shown. Vorapaxar or placebo was given for weeks 0–12 and then stopped. A. Plasma d-dimer (ng/mL), B. Plasma hs-CRP (μg/mL), C. plasma IL-6 (pg/mL).